Message_id,From,Time_stamp,Text
<11286819.1075846157061.JavaMail.evans@thyme>,newsletter@edgar-online.com,2000-06-23 16:03:00,VC SECrets Newsletter Onlines VC SECrets Newsletter Editor Tim Middleton EDGAR Online Analyst VC SECrets contributors include EDGAR Online Analyst Tim Middleton and Venture Capital Contributor Udayan Gupta Udayan covered the venture capital industry for more than a decade as a senior writer for The Wall Street Journal He is the author of the forthcoming book Done Deals Harvard Business School Press an inside story of the venture capital industry ADVERTISEMENTStockPower provides tools to help you turn your customers Into brand loyal shareholding customers Shareholding customers spend more visit more and refer you more frequently Find out why more and more companies are tapping into StockPower to create brand loyalty livestockpowerdefaulthtm To the Editor Stock Option Dangers Overstated by the New York Times Tuesdays June New York Times featured an extensive article on the dangers of stock options The Hidden Cost of Stock Options May Soon Come Back to Haunt As the Times pointed out options carry significant costs especially in a declining or stagnating stock market How Companies must buy back millions of their own shares to offset the stock they have dispensed to employees at much lower prices in options programs The rationale being that if companies did not repurchase their stock there would be so many shares on the market that the companys earnings on a pershare basis would plunge Yes the nations largest nonfinancial companies are spending about of their earnings on stock buyback programs Yes Dell and Microsoft spent several billions dollars apiece last year in stock buyback programs But in reality stock options are not as outofcontrol as the New York Times would have you believe Companies need to get shareholder approval for their stock option grant pools Institutional investors have been putting the breaks on excess share dilution and greedy plans Stock options will continue to be great tax deals for both companies and their employees Without their attractiveness in a tight job market salaries would jump and with that inflation then interest rates then economic downturn We all need to root for the continued appeal of options even with its quirky accounting treatment Look at the global spread of stock options Many countries now view options as the core of the US economic expansion and business spirit Companies must learn to stop pitching options as a get rich quick scheme Instead they should stress the longterm value of options for employees and the link between personal performance company goals and stock options Bruce Brumberg is an attorney and the EditorinChief of myStockOptionscom a new website that will be publicly available soon VC QUESTION OF THE WEEK QUESTION How do I value options in a private company ANSWER If your company is private then you should look at recent grants of options to new employees or at a recent financing round Typically options are granted at fair market value so you will be able to figure out the difference between the exercise price of these recent grants and your exercise price Remember you also need to consider the future growth of the company which is greater on a percentage basis for private companies Valuation of private company stock is much more of an art than a science Bruce Brumberg myStockOptionscom USER NOTE For public companies EDGAR Online makes it easy to find out more about stock option plans option treatment and executive compensation Heres how you can get started Go to ftssearchasp and type stock option into the Search Text box You can further narrow your search by entering stock option granted or stock option exercised You may also choose to limit results by specifying a company or ticker symbol to explore ie ticker symbol DELL or a form group Hint Companies typically disclose stock option grant information in their Proxy Form DEF A or PRE A Advanced User Tip From the Search Text box change stock options to stock options near granted NOTE the phrase stock options must be in quotes Now you have told EDGAR that you want to search all DELL documents in which the phrase stock options is within words of the word granted Try changing the word granted to exercised You may also modify the number of adjacent words Try changing to to widen the scope of your search ADVERTISEMENT Purchase BusinessCredit Reports from Dun Bradstreet on over million US businesses Click on the Resources link when you look up SEC filings for any public company or search by company name and state at VENTURE CAPITAL COMPANY PROFILE by Udayan Gupta Venture Capital Contributor Biotech Startup Emerging as Leader in Memory Loss Treatment By jogging the memory Memory Pharmaceuticals Corp hopes to become a major player in the biotechnology business By treating the symptom of memory loss in diseases such as Alzheimers and Parkinsons the Columbia University startup could well become the next industry star The population Memory is addressing is huge Almost half of all Americans over suffer from Alzheimers disease according to the Chicagobased Alzheimers Association And by the year the number of Americans afflicted by Alzheimers is expected to rise to eight million double the number at the end of the th century Alzheimers is a slow killer It can take anywhere from three to years for a patient to die after being diagnosed the Association said As a result the cost to the healthcare system of keeping an Alzheimers patient alive and functional can be extremely high Companies that can help lessen the impact of Alzheimers are considered extremely valuable to the healthcare system and the afflicted patient Memory is developing a unique drugprofiling platform to create therapies for learning and memoryrelated disorders Called Cognostics the platform identifies cellbased and physiological assays in an effort to treat the symptoms of mild to moderate dementia inability to learn and memory loss caused by Alzheimers Parkinsons and potentially Downs syndrome and epilepsy Cognostics identifies drugs that treat the symptoms not the disease itself Memory plans to develop drugs inhouse and to create others through partnerships with major pharmaceutical companies Memorys larger goal however is to develop a product that will curb or prevent memory loss in the greater population a potentially giant market considering the buying power of the million US baby boomers It is a market that has not gone unnoticed by others Today many other small companies such as American Biogenetic Sciences Inc ABS NeoTherapeutics Inc NEOT and Helicon Therapeutics and large pharmaceutical firms such as Pfizer Inc PFE Shire Pharmaceuticals Group plc SHPGY and Johnson Johnson JNJ are also looking for similar treatments But Memory officials believe that the competitors might become allies especially if the company can develop and test its platform first selling memoryenhancing drugs to graying populations worldwide The technology behind Memory is impeccable Eric Kandel a professor at Columbia Universitys Center for Neurobiology and Behavior and Walter Gilbert Harvard University professor and Nobel laureate started Memory in the mid s Shortly thereafter Axel Unterbeck former head of CNSDementia research at Bayer AG BAYZY joined as president and chief scientific officer Columbia which has an equity stake in the privatelyheld firm granted Memory exclusive rights to develop Kandels patents in return for royalties The company is well backed It has received nearly million in financing from venture capitalists such as Oxford BioScience VenRock Associates HealthCare Ventures Alta Partners and SR One And it is aggressively pursuing corporate partners that can provide capital and infrastructure support In an investment environment in which biotechnology has once again regained investor confidence and companies with strong backers and technology are sought after Memory Pharmaceuticals is well worth watching Memory Phamaceuticals Corp Key Players Venture Fund Investors Oxford Bioscience Partners VenRock Associates HealthCare Ventures LLC Alta Partners SR One Ltd Life Science Ventures GIMV Investors Principal Officers Robert S Cohen CEO and Director Joanne M Leonard Vice President CFO and Treasurer Axel Unterbeck PhD President and Chief Scientific Officer Director and CoFounder VC SECTOR PROFILE Network Infrastructure and ValueAdded Services Companies profiled Flashcom wwwflashcomcom Intira Corporation wwwintiracom Jato Communications wwwjatonet Quantum Shift wwwquantumshiftcom ThinkLink wwwthinklinkcom Most venture capitalists believe in hedging their bets So although they might focus on one broad industry segment they tend not to have too many portfolio companies that are targeting the same customers or the same solutions But there are exceptions The Mayfield Fund one of the few funds that continues to focus on computer technology and the life sciences is convinced that there is a burgeoning market for network infrastructure and the value added services around that infrastructure As DSL Digital Subscriber Line technology becomes more in demand because of its ability to replace modems and T lines and IP Internet Protocol technology becomes a standard for both data and voice transmission companies that are providing infrastructure support and value added services for these technologies can build substantial businesses And as service and infrastructure providers these companies may prove to be more real than many of the Internet shadowcatchers Flashcom wwwflashcomcom Flashcom delivers highspeed DSL access to customers in states through agreements with competitive local exchange carriers Additionally the company has a multiyear agreement with ATT to access ATTs Global Internet system using ATTs Managed Internet Service By focusing exclusively on DSL Flashcom has become the leader in the space EDGAR INSIGHT Flashcom filed an S on May secretsaspdA NOTE Before going public ie selling shares on an exchange companies must file an S form with the SEC This extensive document includes such information as risk factors financials strategy industry management bios and more Venture Fund Investors Mayfield Fund Communications Ventures Intel Corporation Principal Officers Richard Rasmus President and CEO M Wayne Boylston CFO Intira Corporation wwwintiracom Intira acts as an outsourcing resource for companies seeking application hosting hardware and software OS provisioning network connectivity and infrastructure support services Through data centers at its headquarters in Pleasanton CA and in St Louis and New York and through its nationwide broadband network of proprietary management services the company provides seamless infrastructure performance to ebusinesses applications service providers and independent software vendors Venture Fund Investors Mayfield Fund Chase Spectrum Equity NEA Principal Officers Bernie Schneider CEO David S Boone CFO John Steensen Vice President Chief Technology Officer Jato Communications wwwjatonet Jato provides business grade DSL service to small and mediumsized companies in secondary markets directly and through Internet service providers and value added resellers Business grade DSL has been proven to be faster and more reliable than residential grade DSL and cable modems EDGAR INSIGHT Jato filed an S on December and filed a request to withdraw its S May secretsaspdA Venture Fund Investors Mayfield Fund Crest Communications Partners LP CEA Capital Partners USA LP ABN AMRO Capital USA Inc Access Technologies partners Qwest Communications Microsoft Principal Officers Gerald K Dinsmore President and CEO Terri Compton Executive Vice President and COO William D Myers Senior Vice President Finance and Strategic Planning CFO Rex A Humston Senior Vice President Engineering and Chief Technology Officer Quantum Shift wwwquantumshiftcom formerly MVXcom On May MVXCOM changed its name to QuantumShift to better reflect the wideranging changes it is bringing to the telecommunications industry The company offers businesses onestopshopping for telecommunications solutions and implementation strategies Through alliances with US based and international companies it provides an array of communications services from local and long distance to frame relay and ISDN Venture Fund Investors Mayfield Fund Texas Pacific Group Francisco Partners Principal Officers Scott Schaefer President and CEO Edward A Brinskele CoFounder and Chief Technology Officer ThinkLink wwwthinklinkcom ThinkLink is a telecommunications applications service provider offering unified messaging Users are assigned a local number and an number All calls faxes and emails made to the users home office or other locations can be accessed by the user over the phone The service can be bundled and branded by ISPs Internet portals and other companies who want to provide customers with the latest communication technology Venture Fund Investors Mayfield Fund Softbank Technology Ventures Principal Officers David B Ward President and CEO ADVERTISEMENT Subscribe to IPO Express and you can receive company reports Daily wrapups and Weekly summaries of the IPO market sent direct to your desktop Go to for more information COMPANIES MENTIONED IN THIS ISSUE ABN AMRO Capital USA Inc Access Technologies partners Alta Partners American Biogenetic Sciences Inc ATT Bayer AG BioScience CEA Capital Partners USA LP Chase Communications Ventures Crest Communications Partners LP Dell Flashcom Francisco Partners GIMV Investors HealthCare Ventures Helicon Therapeutics Intel Corporation Intira Corporation Jato Communications Johnson Johnson Life Science Ventures Mayfield Fund Memory Pharmaceuticals Corp Microsoft MVXCOM NEA NeoTherapeutics Inc Oxford Bioscience Partners Pfizer Inc Quantum Shift QuantumShift Qwest Communications Shire Pharmaceuticals Group plc Softbank Technology Ventures Spectrum Equity SR One Texas Pacific Group The Mayfield Fund ThinkLink VenRock Associates PEOPLE MENTIONED IN THIS ISSUE Edward A Brinskele David S Boone M Wayne Boylston Robert S Cohen Terri Compton Gerald K Dinsmore Walter Gilbert Rex A Humston Eric Kandel Joanne M Leonard William D Myers Richard Rasmus Scott Schaefer Bernie Schneider John Steensen Axel Unterbeck David B Ward UNSUBSCRIBE INSTRUCTIONS To unsubscribe from the SECrets Newsletter go to authupdateinfoasp and deselect the free newsletter option If you need your user name or password go to usernameasp For help contact Copyright EDGAR Online DISCLAIMER The EDGAR Online report contains observations of its editor Tim Middleton a consultant of EDGAR Online and is for informational purposes only These statements and expressions are the sole opinions of Mr Middleton and EDGAR Online does not endorse nor necessarily agree on such statements and expressions Factual statements in this report are made as of the date stated and are subject to change without notice Nothing contained herein shall be deemed to be recommendations to buy hold or sell securities nor shall it purport to be a complete analysis of the companies mentioned While the information contained in this Report and the opinions contained herein are based on sources believed to be reliable neither Mr Middleton nor EDGAR Online have independently verified the facts assumptions andor estimates that may be contained in this Report Accordingly no representation or warranty expressed or implied is made as to and no reliance should be placed on the fairness accuracy completeness or correctness of the information and opinions contained in this Report 
<27713993.1075846252950.JavaMail.evans@thyme>,newsletter@edgar-online.com,2000-06-23 16:03:00,VC SECrets Newsletter Onlines VC SECrets Newsletter Editor Tim Middleton EDGAR Online Analyst VC SECrets contributors include EDGAR Online Analyst Tim Middleton and Venture Capital Contributor Udayan Gupta Udayan covered the venture capital industry for more than a decade as a senior writer for The Wall Street Journal He is the author of the forthcoming book Done Deals Harvard Business School Press an inside story of the venture capital industry ADVERTISEMENTStockPower provides tools to help you turn your customers Into brand loyal shareholding customers Shareholding customers spend more visit more and refer you more frequently Find out why more and more companies are tapping into StockPower to create brand loyalty livestockpowerdefaulthtm To the Editor Stock Option Dangers Overstated by the New York Times Tuesdays June New York Times featured an extensive article on the dangers of stock options The Hidden Cost of Stock Options May Soon Come Back to Haunt As the Times pointed out options carry significant costs especially in a declining or stagnating stock market How Companies must buy back millions of their own shares to offset the stock they have dispensed to employees at much lower prices in options programs The rationale being that if companies did not repurchase their stock there would be so many shares on the market that the companys earnings on a pershare basis would plunge Yes the nations largest nonfinancial companies are spending about of their earnings on stock buyback programs Yes Dell and Microsoft spent several billions dollars apiece last year in stock buyback programs But in reality stock options are not as outofcontrol as the New York Times would have you believe Companies need to get shareholder approval for their stock option grant pools Institutional investors have been putting the breaks on excess share dilution and greedy plans Stock options will continue to be great tax deals for both companies and their employees Without their attractiveness in a tight job market salaries would jump and with that inflation then interest rates then economic downturn We all need to root for the continued appeal of options even with its quirky accounting treatment Look at the global spread of stock options Many countries now view options as the core of the US economic expansion and business spirit Companies must learn to stop pitching options as a get rich quick scheme Instead they should stress the longterm value of options for employees and the link between personal performance company goals and stock options Bruce Brumberg is an attorney and the EditorinChief of myStockOptionscom a new website that will be publicly available soon VC QUESTION OF THE WEEK QUESTION How do I value options in a private company ANSWER If your company is private then you should look at recent grants of options to new employees or at a recent financing round Typically options are granted at fair market value so you will be able to figure out the difference between the exercise price of these recent grants and your exercise price Remember you also need to consider the future growth of the company which is greater on a percentage basis for private companies Valuation of private company stock is much more of an art than a science Bruce Brumberg myStockOptionscom USER NOTE For public companies EDGAR Online makes it easy to find out more about stock option plans option treatment and executive compensation Heres how you can get started Go to ftssearchasp and type stock option into the Search Text box You can further narrow your search by entering stock option granted or stock option exercised You may also choose to limit results by specifying a company or ticker symbol to explore ie ticker symbol DELL or a form group Hint Companies typically disclose stock option grant information in their Proxy Form DEF A or PRE A Advanced User Tip From the Search Text box change stock options to stock options near granted NOTE the phrase stock options must be in quotes Now you have told EDGAR that you want to search all DELL documents in which the phrase stock options is within words of the word granted Try changing the word granted to exercised You may also modify the number of adjacent words Try changing to to widen the scope of your search ADVERTISEMENT Purchase BusinessCredit Reports from Dun Bradstreet on over million US businesses Click on the Resources link when you look up SEC filings for any public company or search by company name and state at VENTURE CAPITAL COMPANY PROFILE by Udayan Gupta Venture Capital Contributor Biotech Startup Emerging as Leader in Memory Loss Treatment By jogging the memory Memory Pharmaceuticals Corp hopes to become a major player in the biotechnology business By treating the symptom of memory loss in diseases such as Alzheimers and Parkinsons the Columbia University startup could well become the next industry star The population Memory is addressing is huge Almost half of all Americans over suffer from Alzheimers disease according to the Chicagobased Alzheimers Association And by the year the number of Americans afflicted by Alzheimers is expected to rise to eight million double the number at the end of the th century Alzheimers is a slow killer It can take anywhere from three to years for a patient to die after being diagnosed the Association said As a result the cost to the healthcare system of keeping an Alzheimers patient alive and functional can be extremely high Companies that can help lessen the impact of Alzheimers are considered extremely valuable to the healthcare system and the afflicted patient Memory is developing a unique drugprofiling platform to create therapies for learning and memoryrelated disorders Called Cognostics the platform identifies cellbased and physiological assays in an effort to treat the symptoms of mild to moderate dementia inability to learn and memory loss caused by Alzheimers Parkinsons and potentially Downs syndrome and epilepsy Cognostics identifies drugs that treat the symptoms not the disease itself Memory plans to develop drugs inhouse and to create others through partnerships with major pharmaceutical companies Memorys larger goal however is to develop a product that will curb or prevent memory loss in the greater population a potentially giant market considering the buying power of the million US baby boomers It is a market that has not gone unnoticed by others Today many other small companies such as American Biogenetic Sciences Inc ABS NeoTherapeutics Inc NEOT and Helicon Therapeutics and large pharmaceutical firms such as Pfizer Inc PFE Shire Pharmaceuticals Group plc SHPGY and Johnson Johnson JNJ are also looking for similar treatments But Memory officials believe that the competitors might become allies especially if the company can develop and test its platform first selling memoryenhancing drugs to graying populations worldwide The technology behind Memory is impeccable Eric Kandel a professor at Columbia Universitys Center for Neurobiology and Behavior and Walter Gilbert Harvard University professor and Nobel laureate started Memory in the mid s Shortly thereafter Axel Unterbeck former head of CNSDementia research at Bayer AG BAYZY joined as president and chief scientific officer Columbia which has an equity stake in the privatelyheld firm granted Memory exclusive rights to develop Kandels patents in return for royalties The company is well backed It has received nearly million in financing from venture capitalists such as Oxford BioScience VenRock Associates HealthCare Ventures Alta Partners and SR One And it is aggressively pursuing corporate partners that can provide capital and infrastructure support In an investment environment in which biotechnology has once again regained investor confidence and companies with strong backers and technology are sought after Memory Pharmaceuticals is well worth watching Memory Phamaceuticals Corp Key Players Venture Fund Investors Oxford Bioscience Partners VenRock Associates HealthCare Ventures LLC Alta Partners SR One Ltd Life Science Ventures GIMV Investors Principal Officers Robert S Cohen CEO and Director Joanne M Leonard Vice President CFO and Treasurer Axel Unterbeck PhD President and Chief Scientific Officer Director and CoFounder VC SECTOR PROFILE Network Infrastructure and ValueAdded Services Companies profiled Flashcom wwwflashcomcom Intira Corporation wwwintiracom Jato Communications wwwjatonet Quantum Shift wwwquantumshiftcom ThinkLink wwwthinklinkcom Most venture capitalists believe in hedging their bets So although they might focus on one broad industry segment they tend not to have too many portfolio companies that are targeting the same customers or the same solutions But there are exceptions The Mayfield Fund one of the few funds that continues to focus on computer technology and the life sciences is convinced that there is a burgeoning market for network infrastructure and the value added services around that infrastructure As DSL Digital Subscriber Line technology becomes more in demand because of its ability to replace modems and T lines and IP Internet Protocol technology becomes a standard for both data and voice transmission companies that are providing infrastructure support and value added services for these technologies can build substantial businesses And as service and infrastructure providers these companies may prove to be more real than many of the Internet shadowcatchers Flashcom wwwflashcomcom Flashcom delivers highspeed DSL access to customers in states through agreements with competitive local exchange carriers Additionally the company has a multiyear agreement with ATT to access ATTs Global Internet system using ATTs Managed Internet Service By focusing exclusively on DSL Flashcom has become the leader in the space EDGAR INSIGHT Flashcom filed an S on May secretsaspdA NOTE Before going public ie selling shares on an exchange companies must file an S form with the SEC This extensive document includes such information as risk factors financials strategy industry management bios and more Venture Fund Investors Mayfield Fund Communications Ventures Intel Corporation Principal Officers Richard Rasmus President and CEO M Wayne Boylston CFO Intira Corporation wwwintiracom Intira acts as an outsourcing resource for companies seeking application hosting hardware and software OS provisioning network connectivity and infrastructure support services Through data centers at its headquarters in Pleasanton CA and in St Louis and New York and through its nationwide broadband network of proprietary management services the company provides seamless infrastructure performance to ebusinesses applications service providers and independent software vendors Venture Fund Investors Mayfield Fund Chase Spectrum Equity NEA Principal Officers Bernie Schneider CEO David S Boone CFO John Steensen Vice President Chief Technology Officer Jato Communications wwwjatonet Jato provides business grade DSL service to small and mediumsized companies in secondary markets directly and through Internet service providers and value added resellers Business grade DSL has been proven to be faster and more reliable than residential grade DSL and cable modems EDGAR INSIGHT Jato filed an S on December and filed a request to withdraw its S May secretsaspdA Venture Fund Investors Mayfield Fund Crest Communications Partners LP CEA Capital Partners USA LP ABN AMRO Capital USA Inc Access Technologies partners Qwest Communications Microsoft Principal Officers Gerald K Dinsmore President and CEO Terri Compton Executive Vice President and COO William D Myers Senior Vice President Finance and Strategic Planning CFO Rex A Humston Senior Vice President Engineering and Chief Technology Officer Quantum Shift wwwquantumshiftcom formerly MVXcom On May MVXCOM changed its name to QuantumShift to better reflect the wideranging changes it is bringing to the telecommunications industry The company offers businesses onestopshopping for telecommunications solutions and implementation strategies Through alliances with US based and international companies it provides an array of communications services from local and long distance to frame relay and ISDN Venture Fund Investors Mayfield Fund Texas Pacific Group Francisco Partners Principal Officers Scott Schaefer President and CEO Edward A Brinskele CoFounder and Chief Technology Officer ThinkLink wwwthinklinkcom ThinkLink is a telecommunications applications service provider offering unified messaging Users are assigned a local number and an number All calls faxes and emails made to the users home office or other locations can be accessed by the user over the phone The service can be bundled and branded by ISPs Internet portals and other companies who want to provide customers with the latest communication technology Venture Fund Investors Mayfield Fund Softbank Technology Ventures Principal Officers David B Ward President and CEO ADVERTISEMENT Subscribe to IPO Express and you can receive company reports Daily wrapups and Weekly summaries of the IPO market sent direct to your desktop Go to for more information COMPANIES MENTIONED IN THIS ISSUE ABN AMRO Capital USA Inc Access Technologies partners Alta Partners American Biogenetic Sciences Inc ATT Bayer AG BioScience CEA Capital Partners USA LP Chase Communications Ventures Crest Communications Partners LP Dell Flashcom Francisco Partners GIMV Investors HealthCare Ventures Helicon Therapeutics Intel Corporation Intira Corporation Jato Communications Johnson Johnson Life Science Ventures Mayfield Fund Memory Pharmaceuticals Corp Microsoft MVXCOM NEA NeoTherapeutics Inc Oxford Bioscience Partners Pfizer Inc Quantum Shift QuantumShift Qwest Communications Shire Pharmaceuticals Group plc Softbank Technology Ventures Spectrum Equity SR One Texas Pacific Group The Mayfield Fund ThinkLink VenRock Associates PEOPLE MENTIONED IN THIS ISSUE Edward A Brinskele David S Boone M Wayne Boylston Robert S Cohen Terri Compton Gerald K Dinsmore Walter Gilbert Rex A Humston Eric Kandel Joanne M Leonard William D Myers Richard Rasmus Scott Schaefer Bernie Schneider John Steensen Axel Unterbeck David B Ward UNSUBSCRIBE INSTRUCTIONS To unsubscribe from the SECrets Newsletter go to authupdateinfoasp and deselect the free newsletter option If you need your user name or password go to usernameasp For help contact Copyright EDGAR Online DISCLAIMER The EDGAR Online report contains observations of its editor Tim Middleton a consultant of EDGAR Online and is for informational purposes only These statements and expressions are the sole opinions of Mr Middleton and EDGAR Online does not endorse nor necessarily agree on such statements and expressions Factual statements in this report are made as of the date stated and are subject to change without notice Nothing contained herein shall be deemed to be recommendations to buy hold or sell securities nor shall it purport to be a complete analysis of the companies mentioned While the information contained in this Report and the opinions contained herein are based on sources believed to be reliable neither Mr Middleton nor EDGAR Online have independently verified the facts assumptions andor estimates that may be contained in this Report Accordingly no representation or warranty expressed or implied is made as to and no reliance should be placed on the fairness accuracy completeness or correctness of the information and opinions contained in this Report 
<10431627.1075846288198.JavaMail.evans@thyme>,newsletter@edgar-online.com,2000-06-23 16:03:00,VC SECrets Newsletter Onlines VC SECrets Newsletter Editor Tim Middleton EDGAR Online Analyst VC SECrets contributors include EDGAR Online Analyst Tim Middleton and Venture Capital Contributor Udayan Gupta Udayan covered the venture capital industry for more than a decade as a senior writer for The Wall Street Journal He is the author of the forthcoming book Done Deals Harvard Business School Press an inside story of the venture capital industry ADVERTISEMENTStockPower provides tools to help you turn your customers Into brand loyal shareholding customers Shareholding customers spend more visit more and refer you more frequently Find out why more and more companies are tapping into StockPower to create brand loyalty livestockpowerdefaulthtm To the Editor Stock Option Dangers Overstated by the New York Times Tuesdays June New York Times featured an extensive article on the dangers of stock options The Hidden Cost of Stock Options May Soon Come Back to Haunt As the Times pointed out options carry significant costs especially in a declining or stagnating stock market How Companies must buy back millions of their own shares to offset the stock they have dispensed to employees at much lower prices in options programs The rationale being that if companies did not repurchase their stock there would be so many shares on the market that the companys earnings on a pershare basis would plunge Yes the nations largest nonfinancial companies are spending about of their earnings on stock buyback programs Yes Dell and Microsoft spent several billions dollars apiece last year in stock buyback programs But in reality stock options are not as outofcontrol as the New York Times would have you believe Companies need to get shareholder approval for their stock option grant pools Institutional investors have been putting the breaks on excess share dilution and greedy plans Stock options will continue to be great tax deals for both companies and their employees Without their attractiveness in a tight job market salaries would jump and with that inflation then interest rates then economic downturn We all need to root for the continued appeal of options even with its quirky accounting treatment Look at the global spread of stock options Many countries now view options as the core of the US economic expansion and business spirit Companies must learn to stop pitching options as a get rich quick scheme Instead they should stress the longterm value of options for employees and the link between personal performance company goals and stock options Bruce Brumberg is an attorney and the EditorinChief of myStockOptionscom a new website that will be publicly available soon VC QUESTION OF THE WEEK QUESTION How do I value options in a private company ANSWER If your company is private then you should look at recent grants of options to new employees or at a recent financing round Typically options are granted at fair market value so you will be able to figure out the difference between the exercise price of these recent grants and your exercise price Remember you also need to consider the future growth of the company which is greater on a percentage basis for private companies Valuation of private company stock is much more of an art than a science Bruce Brumberg myStockOptionscom USER NOTE For public companies EDGAR Online makes it easy to find out more about stock option plans option treatment and executive compensation Heres how you can get started Go to ftssearchasp and type stock option into the Search Text box You can further narrow your search by entering stock option granted or stock option exercised You may also choose to limit results by specifying a company or ticker symbol to explore ie ticker symbol DELL or a form group Hint Companies typically disclose stock option grant information in their Proxy Form DEF A or PRE A Advanced User Tip From the Search Text box change stock options to stock options near granted NOTE the phrase stock options must be in quotes Now you have told EDGAR that you want to search all DELL documents in which the phrase stock options is within words of the word granted Try changing the word granted to exercised You may also modify the number of adjacent words Try changing to to widen the scope of your search ADVERTISEMENT Purchase BusinessCredit Reports from Dun Bradstreet on over million US businesses Click on the Resources link when you look up SEC filings for any public company or search by company name and state at VENTURE CAPITAL COMPANY PROFILE by Udayan Gupta Venture Capital Contributor Biotech Startup Emerging as Leader in Memory Loss Treatment By jogging the memory Memory Pharmaceuticals Corp hopes to become a major player in the biotechnology business By treating the symptom of memory loss in diseases such as Alzheimers and Parkinsons the Columbia University startup could well become the next industry star The population Memory is addressing is huge Almost half of all Americans over suffer from Alzheimers disease according to the Chicagobased Alzheimers Association And by the year the number of Americans afflicted by Alzheimers is expected to rise to eight million double the number at the end of the th century Alzheimers is a slow killer It can take anywhere from three to years for a patient to die after being diagnosed the Association said As a result the cost to the healthcare system of keeping an Alzheimers patient alive and functional can be extremely high Companies that can help lessen the impact of Alzheimers are considered extremely valuable to the healthcare system and the afflicted patient Memory is developing a unique drugprofiling platform to create therapies for learning and memoryrelated disorders Called Cognostics the platform identifies cellbased and physiological assays in an effort to treat the symptoms of mild to moderate dementia inability to learn and memory loss caused by Alzheimers Parkinsons and potentially Downs syndrome and epilepsy Cognostics identifies drugs that treat the symptoms not the disease itself Memory plans to develop drugs inhouse and to create others through partnerships with major pharmaceutical companies Memorys larger goal however is to develop a product that will curb or prevent memory loss in the greater population a potentially giant market considering the buying power of the million US baby boomers It is a market that has not gone unnoticed by others Today many other small companies such as American Biogenetic Sciences Inc ABS NeoTherapeutics Inc NEOT and Helicon Therapeutics and large pharmaceutical firms such as Pfizer Inc PFE Shire Pharmaceuticals Group plc SHPGY and Johnson Johnson JNJ are also looking for similar treatments But Memory officials believe that the competitors might become allies especially if the company can develop and test its platform first selling memoryenhancing drugs to graying populations worldwide The technology behind Memory is impeccable Eric Kandel a professor at Columbia Universitys Center for Neurobiology and Behavior and Walter Gilbert Harvard University professor and Nobel laureate started Memory in the mid s Shortly thereafter Axel Unterbeck former head of CNSDementia research at Bayer AG BAYZY joined as president and chief scientific officer Columbia which has an equity stake in the privatelyheld firm granted Memory exclusive rights to develop Kandels patents in return for royalties The company is well backed It has received nearly million in financing from venture capitalists such as Oxford BioScience VenRock Associates HealthCare Ventures Alta Partners and SR One And it is aggressively pursuing corporate partners that can provide capital and infrastructure support In an investment environment in which biotechnology has once again regained investor confidence and companies with strong backers and technology are sought after Memory Pharmaceuticals is well worth watching Memory Phamaceuticals Corp Key Players Venture Fund Investors Oxford Bioscience Partners VenRock Associates HealthCare Ventures LLC Alta Partners SR One Ltd Life Science Ventures GIMV Investors Principal Officers Robert S Cohen CEO and Director Joanne M Leonard Vice President CFO and Treasurer Axel Unterbeck PhD President and Chief Scientific Officer Director and CoFounder VC SECTOR PROFILE Network Infrastructure and ValueAdded Services Companies profiled Flashcom wwwflashcomcom Intira Corporation wwwintiracom Jato Communications wwwjatonet Quantum Shift wwwquantumshiftcom ThinkLink wwwthinklinkcom Most venture capitalists believe in hedging their bets So although they might focus on one broad industry segment they tend not to have too many portfolio companies that are targeting the same customers or the same solutions But there are exceptions The Mayfield Fund one of the few funds that continues to focus on computer technology and the life sciences is convinced that there is a burgeoning market for network infrastructure and the value added services around that infrastructure As DSL Digital Subscriber Line technology becomes more in demand because of its ability to replace modems and T lines and IP Internet Protocol technology becomes a standard for both data and voice transmission companies that are providing infrastructure support and value added services for these technologies can build substantial businesses And as service and infrastructure providers these companies may prove to be more real than many of the Internet shadowcatchers Flashcom wwwflashcomcom Flashcom delivers highspeed DSL access to customers in states through agreements with competitive local exchange carriers Additionally the company has a multiyear agreement with ATT to access ATTs Global Internet system using ATTs Managed Internet Service By focusing exclusively on DSL Flashcom has become the leader in the space EDGAR INSIGHT Flashcom filed an S on May secretsaspdA NOTE Before going public ie selling shares on an exchange companies must file an S form with the SEC This extensive document includes such information as risk factors financials strategy industry management bios and more Venture Fund Investors Mayfield Fund Communications Ventures Intel Corporation Principal Officers Richard Rasmus President and CEO M Wayne Boylston CFO Intira Corporation wwwintiracom Intira acts as an outsourcing resource for companies seeking application hosting hardware and software OS provisioning network connectivity and infrastructure support services Through data centers at its headquarters in Pleasanton CA and in St Louis and New York and through its nationwide broadband network of proprietary management services the company provides seamless infrastructure performance to ebusinesses applications service providers and independent software vendors Venture Fund Investors Mayfield Fund Chase Spectrum Equity NEA Principal Officers Bernie Schneider CEO David S Boone CFO John Steensen Vice President Chief Technology Officer Jato Communications wwwjatonet Jato provides business grade DSL service to small and mediumsized companies in secondary markets directly and through Internet service providers and value added resellers Business grade DSL has been proven to be faster and more reliable than residential grade DSL and cable modems EDGAR INSIGHT Jato filed an S on December and filed a request to withdraw its S May secretsaspdA Venture Fund Investors Mayfield Fund Crest Communications Partners LP CEA Capital Partners USA LP ABN AMRO Capital USA Inc Access Technologies partners Qwest Communications Microsoft Principal Officers Gerald K Dinsmore President and CEO Terri Compton Executive Vice President and COO William D Myers Senior Vice President Finance and Strategic Planning CFO Rex A Humston Senior Vice President Engineering and Chief Technology Officer Quantum Shift wwwquantumshiftcom formerly MVXcom On May MVXCOM changed its name to QuantumShift to better reflect the wideranging changes it is bringing to the telecommunications industry The company offers businesses onestopshopping for telecommunications solutions and implementation strategies Through alliances with US based and international companies it provides an array of communications services from local and long distance to frame relay and ISDN Venture Fund Investors Mayfield Fund Texas Pacific Group Francisco Partners Principal Officers Scott Schaefer President and CEO Edward A Brinskele CoFounder and Chief Technology Officer ThinkLink wwwthinklinkcom ThinkLink is a telecommunications applications service provider offering unified messaging Users are assigned a local number and an number All calls faxes and emails made to the users home office or other locations can be accessed by the user over the phone The service can be bundled and branded by ISPs Internet portals and other companies who want to provide customers with the latest communication technology Venture Fund Investors Mayfield Fund Softbank Technology Ventures Principal Officers David B Ward President and CEO ADVERTISEMENT Subscribe to IPO Express and you can receive company reports Daily wrapups and Weekly summaries of the IPO market sent direct to your desktop Go to for more information COMPANIES MENTIONED IN THIS ISSUE ABN AMRO Capital USA Inc Access Technologies partners Alta Partners American Biogenetic Sciences Inc ATT Bayer AG BioScience CEA Capital Partners USA LP Chase Communications Ventures Crest Communications Partners LP Dell Flashcom Francisco Partners GIMV Investors HealthCare Ventures Helicon Therapeutics Intel Corporation Intira Corporation Jato Communications Johnson Johnson Life Science Ventures Mayfield Fund Memory Pharmaceuticals Corp Microsoft MVXCOM NEA NeoTherapeutics Inc Oxford Bioscience Partners Pfizer Inc Quantum Shift QuantumShift Qwest Communications Shire Pharmaceuticals Group plc Softbank Technology Ventures Spectrum Equity SR One Texas Pacific Group The Mayfield Fund ThinkLink VenRock Associates PEOPLE MENTIONED IN THIS ISSUE Edward A Brinskele David S Boone M Wayne Boylston Robert S Cohen Terri Compton Gerald K Dinsmore Walter Gilbert Rex A Humston Eric Kandel Joanne M Leonard William D Myers Richard Rasmus Scott Schaefer Bernie Schneider John Steensen Axel Unterbeck David B Ward UNSUBSCRIBE INSTRUCTIONS To unsubscribe from the SECrets Newsletter go to authupdateinfoasp and deselect the free newsletter option If you need your user name or password go to usernameasp For help contact Copyright EDGAR Online DISCLAIMER The EDGAR Online report contains observations of its editor Tim Middleton a consultant of EDGAR Online and is for informational purposes only These statements and expressions are the sole opinions of Mr Middleton and EDGAR Online does not endorse nor necessarily agree on such statements and expressions Factual statements in this report are made as of the date stated and are subject to change without notice Nothing contained herein shall be deemed to be recommendations to buy hold or sell securities nor shall it purport to be a complete analysis of the companies mentioned While the information contained in this Report and the opinions contained herein are based on sources believed to be reliable neither Mr Middleton nor EDGAR Online have independently verified the facts assumptions andor estimates that may be contained in this Report Accordingly no representation or warranty expressed or implied is made as to and no reliance should be placed on the fairness accuracy completeness or correctness of the information and opinions contained in this Report 
<28086339.1075848084941.JavaMail.evans@thyme>,newsletter@edgar-online.com,2000-06-23 16:03:00,VC SECrets Newsletter Onlines VC SECrets Newsletter Editor Tim Middleton EDGAR Online Analyst VC SECrets contributors include EDGAR Online Analyst Tim Middleton and Venture Capital Contributor Udayan Gupta Udayan covered the venture capital industry for more than a decade as a senior writer for The Wall Street Journal He is the author of the forthcoming book Done Deals Harvard Business School Press an inside story of the venture capital industry ADVERTISEMENTStockPower provides tools to help you turn your customers Into brand loyal shareholding customers Shareholding customers spend more visit more and refer you more frequently Find out why more and more companies are tapping into StockPower to create brand loyalty livestockpowerdefaulthtm To the Editor Stock Option Dangers Overstated by the New York Times Tuesdays June New York Times featured an extensive article on the dangers of stock options The Hidden Cost of Stock Options May Soon Come Back to Haunt As the Times pointed out options carry significant costs especially in a declining or stagnating stock market How Companies must buy back millions of their own shares to offset the stock they have dispensed to employees at much lower prices in options programs The rationale being that if companies did not repurchase their stock there would be so many shares on the market that the companys earnings on a pershare basis would plunge Yes the nations largest nonfinancial companies are spending about of their earnings on stock buyback programs Yes Dell and Microsoft spent several billions dollars apiece last year in stock buyback programs But in reality stock options are not as outofcontrol as the New York Times would have you believe Companies need to get shareholder approval for their stock option grant pools Institutional investors have been putting the breaks on excess share dilution and greedy plans Stock options will continue to be great tax deals for both companies and their employees Without their attractiveness in a tight job market salaries would jump and with that inflation then interest rates then economic downturn We all need to root for the continued appeal of options even with its quirky accounting treatment Look at the global spread of stock options Many countries now view options as the core of the US economic expansion and business spirit Companies must learn to stop pitching options as a get rich quick scheme Instead they should stress the longterm value of options for employees and the link between personal performance company goals and stock options Bruce Brumberg is an attorney and the EditorinChief of myStockOptionscom a new website that will be publicly available soon VC QUESTION OF THE WEEK QUESTION How do I value options in a private company ANSWER If your company is private then you should look at recent grants of options to new employees or at a recent financing round Typically options are granted at fair market value so you will be able to figure out the difference between the exercise price of these recent grants and your exercise price Remember you also need to consider the future growth of the company which is greater on a percentage basis for private companies Valuation of private company stock is much more of an art than a science Bruce Brumberg myStockOptionscom USER NOTE For public companies EDGAR Online makes it easy to find out more about stock option plans option treatment and executive compensation Heres how you can get started Go to ftssearchasp and type stock option into the Search Text box You can further narrow your search by entering stock option granted or stock option exercised You may also choose to limit results by specifying a company or ticker symbol to explore ie ticker symbol DELL or a form group Hint Companies typically disclose stock option grant information in their Proxy Form DEF A or PRE A Advanced User Tip From the Search Text box change stock options to stock options near granted NOTE the phrase stock options must be in quotes Now you have told EDGAR that you want to search all DELL documents in which the phrase stock options is within words of the word granted Try changing the word granted to exercised You may also modify the number of adjacent words Try changing to to widen the scope of your search ADVERTISEMENT Purchase BusinessCredit Reports from Dun Bradstreet on over million US businesses Click on the Resources link when you look up SEC filings for any public company or search by company name and state at VENTURE CAPITAL COMPANY PROFILE by Udayan Gupta Venture Capital Contributor Biotech Startup Emerging as Leader in Memory Loss Treatment By jogging the memory Memory Pharmaceuticals Corp hopes to become a major player in the biotechnology business By treating the symptom of memory loss in diseases such as Alzheimers and Parkinsons the Columbia University startup could well become the next industry star The population Memory is addressing is huge Almost half of all Americans over suffer from Alzheimers disease according to the Chicagobased Alzheimers Association And by the year the number of Americans afflicted by Alzheimers is expected to rise to eight million double the number at the end of the th century Alzheimers is a slow killer It can take anywhere from three to years for a patient to die after being diagnosed the Association said As a result the cost to the healthcare system of keeping an Alzheimers patient alive and functional can be extremely high Companies that can help lessen the impact of Alzheimers are considered extremely valuable to the healthcare system and the afflicted patient Memory is developing a unique drugprofiling platform to create therapies for learning and memoryrelated disorders Called Cognostics the platform identifies cellbased and physiological assays in an effort to treat the symptoms of mild to moderate dementia inability to learn and memory loss caused by Alzheimers Parkinsons and potentially Downs syndrome and epilepsy Cognostics identifies drugs that treat the symptoms not the disease itself Memory plans to develop drugs inhouse and to create others through partnerships with major pharmaceutical companies Memorys larger goal however is to develop a product that will curb or prevent memory loss in the greater population a potentially giant market considering the buying power of the million US baby boomers It is a market that has not gone unnoticed by others Today many other small companies such as American Biogenetic Sciences Inc ABS NeoTherapeutics Inc NEOT and Helicon Therapeutics and large pharmaceutical firms such as Pfizer Inc PFE Shire Pharmaceuticals Group plc SHPGY and Johnson Johnson JNJ are also looking for similar treatments But Memory officials believe that the competitors might become allies especially if the company can develop and test its platform first selling memoryenhancing drugs to graying populations worldwide The technology behind Memory is impeccable Eric Kandel a professor at Columbia Universitys Center for Neurobiology and Behavior and Walter Gilbert Harvard University professor and Nobel laureate started Memory in the mid s Shortly thereafter Axel Unterbeck former head of CNSDementia research at Bayer AG BAYZY joined as president and chief scientific officer Columbia which has an equity stake in the privatelyheld firm granted Memory exclusive rights to develop Kandels patents in return for royalties The company is well backed It has received nearly million in financing from venture capitalists such as Oxford BioScience VenRock Associates HealthCare Ventures Alta Partners and SR One And it is aggressively pursuing corporate partners that can provide capital and infrastructure support In an investment environment in which biotechnology has once again regained investor confidence and companies with strong backers and technology are sought after Memory Pharmaceuticals is well worth watching Memory Phamaceuticals Corp Key Players Venture Fund Investors Oxford Bioscience Partners VenRock Associates HealthCare Ventures LLC Alta Partners SR One Ltd Life Science Ventures GIMV Investors Principal Officers Robert S Cohen CEO and Director Joanne M Leonard Vice President CFO and Treasurer Axel Unterbeck PhD President and Chief Scientific Officer Director and CoFounder VC SECTOR PROFILE Network Infrastructure and ValueAdded Services Companies profiled Flashcom wwwflashcomcom Intira Corporation wwwintiracom Jato Communications wwwjatonet Quantum Shift wwwquantumshiftcom ThinkLink wwwthinklinkcom Most venture capitalists believe in hedging their bets So although they might focus on one broad industry segment they tend not to have too many portfolio companies that are targeting the same customers or the same solutions But there are exceptions The Mayfield Fund one of the few funds that continues to focus on computer technology and the life sciences is convinced that there is a burgeoning market for network infrastructure and the value added services around that infrastructure As DSL Digital Subscriber Line technology becomes more in demand because of its ability to replace modems and T lines and IP Internet Protocol technology becomes a standard for both data and voice transmission companies that are providing infrastructure support and value added services for these technologies can build substantial businesses And as service and infrastructure providers these companies may prove to be more real than many of the Internet shadowcatchers Flashcom wwwflashcomcom Flashcom delivers highspeed DSL access to customers in states through agreements with competitive local exchange carriers Additionally the company has a multiyear agreement with ATT to access ATTs Global Internet system using ATTs Managed Internet Service By focusing exclusively on DSL Flashcom has become the leader in the space EDGAR INSIGHT Flashcom filed an S on May secretsaspdA NOTE Before going public ie selling shares on an exchange companies must file an S form with the SEC This extensive document includes such information as risk factors financials strategy industry management bios and more Venture Fund Investors Mayfield Fund Communications Ventures Intel Corporation Principal Officers Richard Rasmus President and CEO M Wayne Boylston CFO Intira Corporation wwwintiracom Intira acts as an outsourcing resource for companies seeking application hosting hardware and software OS provisioning network connectivity and infrastructure support services Through data centers at its headquarters in Pleasanton CA and in St Louis and New York and through its nationwide broadband network of proprietary management services the company provides seamless infrastructure performance to ebusinesses applications service providers and independent software vendors Venture Fund Investors Mayfield Fund Chase Spectrum Equity NEA Principal Officers Bernie Schneider CEO David S Boone CFO John Steensen Vice President Chief Technology Officer Jato Communications wwwjatonet Jato provides business grade DSL service to small and mediumsized companies in secondary markets directly and through Internet service providers and value added resellers Business grade DSL has been proven to be faster and more reliable than residential grade DSL and cable modems EDGAR INSIGHT Jato filed an S on December and filed a request to withdraw its S May secretsaspdA Venture Fund Investors Mayfield Fund Crest Communications Partners LP CEA Capital Partners USA LP ABN AMRO Capital USA Inc Access Technologies partners Qwest Communications Microsoft Principal Officers Gerald K Dinsmore President and CEO Terri Compton Executive Vice President and COO William D Myers Senior Vice President Finance and Strategic Planning CFO Rex A Humston Senior Vice President Engineering and Chief Technology Officer Quantum Shift wwwquantumshiftcom formerly MVXcom On May MVXCOM changed its name to QuantumShift to better reflect the wideranging changes it is bringing to the telecommunications industry The company offers businesses onestopshopping for telecommunications solutions and implementation strategies Through alliances with US based and international companies it provides an array of communications services from local and long distance to frame relay and ISDN Venture Fund Investors Mayfield Fund Texas Pacific Group Francisco Partners Principal Officers Scott Schaefer President and CEO Edward A Brinskele CoFounder and Chief Technology Officer ThinkLink wwwthinklinkcom ThinkLink is a telecommunications applications service provider offering unified messaging Users are assigned a local number and an number All calls faxes and emails made to the users home office or other locations can be accessed by the user over the phone The service can be bundled and branded by ISPs Internet portals and other companies who want to provide customers with the latest communication technology Venture Fund Investors Mayfield Fund Softbank Technology Ventures Principal Officers David B Ward President and CEO ADVERTISEMENT Subscribe to IPO Express and you can receive company reports Daily wrapups and Weekly summaries of the IPO market sent direct to your desktop Go to for more information COMPANIES MENTIONED IN THIS ISSUE ABN AMRO Capital USA Inc Access Technologies partners Alta Partners American Biogenetic Sciences Inc ATT Bayer AG BioScience CEA Capital Partners USA LP Chase Communications Ventures Crest Communications Partners LP Dell Flashcom Francisco Partners GIMV Investors HealthCare Ventures Helicon Therapeutics Intel Corporation Intira Corporation Jato Communications Johnson Johnson Life Science Ventures Mayfield Fund Memory Pharmaceuticals Corp Microsoft MVXCOM NEA NeoTherapeutics Inc Oxford Bioscience Partners Pfizer Inc Quantum Shift QuantumShift Qwest Communications Shire Pharmaceuticals Group plc Softbank Technology Ventures Spectrum Equity SR One Texas Pacific Group The Mayfield Fund ThinkLink VenRock Associates PEOPLE MENTIONED IN THIS ISSUE Edward A Brinskele David S Boone M Wayne Boylston Robert S Cohen Terri Compton Gerald K Dinsmore Walter Gilbert Rex A Humston Eric Kandel Joanne M Leonard William D Myers Richard Rasmus Scott Schaefer Bernie Schneider John Steensen Axel Unterbeck David B Ward UNSUBSCRIBE INSTRUCTIONS To unsubscribe from the SECrets Newsletter go to authupdateinfoasp and deselect the free newsletter option If you need your user name or password go to usernameasp For help contact Copyright EDGAR Online DISCLAIMER The EDGAR Online report contains observations of its editor Tim Middleton a consultant of EDGAR Online and is for informational purposes only These statements and expressions are the sole opinions of Mr Middleton and EDGAR Online does not endorse nor necessarily agree on such statements and expressions Factual statements in this report are made as of the date stated and are subject to change without notice Nothing contained herein shall be deemed to be recommendations to buy hold or sell securities nor shall it purport to be a complete analysis of the companies mentioned While the information contained in this Report and the opinions contained herein are based on sources believed to be reliable neither Mr Middleton nor EDGAR Online have independently verified the facts assumptions andor estimates that may be contained in this Report Accordingly no representation or warranty expressed or implied is made as to and no reliance should be placed on the fairness accuracy completeness or correctness of the information and opinions contained in this Report 
<27980181.1075846371446.JavaMail.evans@thyme>,newsletter@edgar-online.com,2000-06-23 16:03:00,VC SECrets Newsletter Onlines VC SECrets Newsletter Editor Tim Middleton EDGAR Online Analyst VC SECrets contributors include EDGAR Online Analyst Tim Middleton and Venture Capital Contributor Udayan Gupta Udayan covered the venture capital industry for more than a decade as a senior writer for The Wall Street Journal He is the author of the forthcoming book Done Deals Harvard Business School Press an inside story of the venture capital industry ADVERTISEMENTStockPower provides tools to help you turn your customers Into brand loyal shareholding customers Shareholding customers spend more visit more and refer you more frequently Find out why more and more companies are tapping into StockPower to create brand loyalty livestockpowerdefaulthtm To the Editor Stock Option Dangers Overstated by the New York Times Tuesdays June New York Times featured an extensive article on the dangers of stock options The Hidden Cost of Stock Options May Soon Come Back to Haunt As the Times pointed out options carry significant costs especially in a declining or stagnating stock market How Companies must buy back millions of their own shares to offset the stock they have dispensed to employees at much lower prices in options programs The rationale being that if companies did not repurchase their stock there would be so many shares on the market that the companys earnings on a pershare basis would plunge Yes the nations largest nonfinancial companies are spending about of their earnings on stock buyback programs Yes Dell and Microsoft spent several billions dollars apiece last year in stock buyback programs But in reality stock options are not as outofcontrol as the New York Times would have you believe Companies need to get shareholder approval for their stock option grant pools Institutional investors have been putting the breaks on excess share dilution and greedy plans Stock options will continue to be great tax deals for both companies and their employees Without their attractiveness in a tight job market salaries would jump and with that inflation then interest rates then economic downturn We all need to root for the continued appeal of options even with its quirky accounting treatment Look at the global spread of stock options Many countries now view options as the core of the US economic expansion and business spirit Companies must learn to stop pitching options as a get rich quick scheme Instead they should stress the longterm value of options for employees and the link between personal performance company goals and stock options Bruce Brumberg is an attorney and the EditorinChief of myStockOptionscom a new website that will be publicly available soon VC QUESTION OF THE WEEK QUESTION How do I value options in a private company ANSWER If your company is private then you should look at recent grants of options to new employees or at a recent financing round Typically options are granted at fair market value so you will be able to figure out the difference between the exercise price of these recent grants and your exercise price Remember you also need to consider the future growth of the company which is greater on a percentage basis for private companies Valuation of private company stock is much more of an art than a science Bruce Brumberg myStockOptionscom USER NOTE For public companies EDGAR Online makes it easy to find out more about stock option plans option treatment and executive compensation Heres how you can get started Go to ftssearchasp and type stock option into the Search Text box You can further narrow your search by entering stock option granted or stock option exercised You may also choose to limit results by specifying a company or ticker symbol to explore ie ticker symbol DELL or a form group Hint Companies typically disclose stock option grant information in their Proxy Form DEF A or PRE A Advanced User Tip From the Search Text box change stock options to stock options near granted NOTE the phrase stock options must be in quotes Now you have told EDGAR that you want to search all DELL documents in which the phrase stock options is within words of the word granted Try changing the word granted to exercised You may also modify the number of adjacent words Try changing to to widen the scope of your search ADVERTISEMENT Purchase BusinessCredit Reports from Dun Bradstreet on over million US businesses Click on the Resources link when you look up SEC filings for any public company or search by company name and state at VENTURE CAPITAL COMPANY PROFILE by Udayan Gupta Venture Capital Contributor Biotech Startup Emerging as Leader in Memory Loss Treatment By jogging the memory Memory Pharmaceuticals Corp hopes to become a major player in the biotechnology business By treating the symptom of memory loss in diseases such as Alzheimers and Parkinsons the Columbia University startup could well become the next industry star The population Memory is addressing is huge Almost half of all Americans over suffer from Alzheimers disease according to the Chicagobased Alzheimers Association And by the year the number of Americans afflicted by Alzheimers is expected to rise to eight million double the number at the end of the th century Alzheimers is a slow killer It can take anywhere from three to years for a patient to die after being diagnosed the Association said As a result the cost to the healthcare system of keeping an Alzheimers patient alive and functional can be extremely high Companies that can help lessen the impact of Alzheimers are considered extremely valuable to the healthcare system and the afflicted patient Memory is developing a unique drugprofiling platform to create therapies for learning and memoryrelated disorders Called Cognostics the platform identifies cellbased and physiological assays in an effort to treat the symptoms of mild to moderate dementia inability to learn and memory loss caused by Alzheimers Parkinsons and potentially Downs syndrome and epilepsy Cognostics identifies drugs that treat the symptoms not the disease itself Memory plans to develop drugs inhouse and to create others through partnerships with major pharmaceutical companies Memorys larger goal however is to develop a product that will curb or prevent memory loss in the greater population a potentially giant market considering the buying power of the million US baby boomers It is a market that has not gone unnoticed by others Today many other small companies such as American Biogenetic Sciences Inc ABS NeoTherapeutics Inc NEOT and Helicon Therapeutics and large pharmaceutical firms such as Pfizer Inc PFE Shire Pharmaceuticals Group plc SHPGY and Johnson Johnson JNJ are also looking for similar treatments But Memory officials believe that the competitors might become allies especially if the company can develop and test its platform first selling memoryenhancing drugs to graying populations worldwide The technology behind Memory is impeccable Eric Kandel a professor at Columbia Universitys Center for Neurobiology and Behavior and Walter Gilbert Harvard University professor and Nobel laureate started Memory in the mid s Shortly thereafter Axel Unterbeck former head of CNSDementia research at Bayer AG BAYZY joined as president and chief scientific officer Columbia which has an equity stake in the privatelyheld firm granted Memory exclusive rights to develop Kandels patents in return for royalties The company is well backed It has received nearly million in financing from venture capitalists such as Oxford BioScience VenRock Associates HealthCare Ventures Alta Partners and SR One And it is aggressively pursuing corporate partners that can provide capital and infrastructure support In an investment environment in which biotechnology has once again regained investor confidence and companies with strong backers and technology are sought after Memory Pharmaceuticals is well worth watching Memory Phamaceuticals Corp Key Players Venture Fund Investors Oxford Bioscience Partners VenRock Associates HealthCare Ventures LLC Alta Partners SR One Ltd Life Science Ventures GIMV Investors Principal Officers Robert S Cohen CEO and Director Joanne M Leonard Vice President CFO and Treasurer Axel Unterbeck PhD President and Chief Scientific Officer Director and CoFounder VC SECTOR PROFILE Network Infrastructure and ValueAdded Services Companies profiled Flashcom wwwflashcomcom Intira Corporation wwwintiracom Jato Communications wwwjatonet Quantum Shift wwwquantumshiftcom ThinkLink wwwthinklinkcom Most venture capitalists believe in hedging their bets So although they might focus on one broad industry segment they tend not to have too many portfolio companies that are targeting the same customers or the same solutions But there are exceptions The Mayfield Fund one of the few funds that continues to focus on computer technology and the life sciences is convinced that there is a burgeoning market for network infrastructure and the value added services around that infrastructure As DSL Digital Subscriber Line technology becomes more in demand because of its ability to replace modems and T lines and IP Internet Protocol technology becomes a standard for both data and voice transmission companies that are providing infrastructure support and value added services for these technologies can build substantial businesses And as service and infrastructure providers these companies may prove to be more real than many of the Internet shadowcatchers Flashcom wwwflashcomcom Flashcom delivers highspeed DSL access to customers in states through agreements with competitive local exchange carriers Additionally the company has a multiyear agreement with ATT to access ATTs Global Internet system using ATTs Managed Internet Service By focusing exclusively on DSL Flashcom has become the leader in the space EDGAR INSIGHT Flashcom filed an S on May secretsaspdA NOTE Before going public ie selling shares on an exchange companies must file an S form with the SEC This extensive document includes such information as risk factors financials strategy industry management bios and more Venture Fund Investors Mayfield Fund Communications Ventures Intel Corporation Principal Officers Richard Rasmus President and CEO M Wayne Boylston CFO Intira Corporation wwwintiracom Intira acts as an outsourcing resource for companies seeking application hosting hardware and software OS provisioning network connectivity and infrastructure support services Through data centers at its headquarters in Pleasanton CA and in St Louis and New York and through its nationwide broadband network of proprietary management services the company provides seamless infrastructure performance to ebusinesses applications service providers and independent software vendors Venture Fund Investors Mayfield Fund Chase Spectrum Equity NEA Principal Officers Bernie Schneider CEO David S Boone CFO John Steensen Vice President Chief Technology Officer Jato Communications wwwjatonet Jato provides business grade DSL service to small and mediumsized companies in secondary markets directly and through Internet service providers and value added resellers Business grade DSL has been proven to be faster and more reliable than residential grade DSL and cable modems EDGAR INSIGHT Jato filed an S on December and filed a request to withdraw its S May secretsaspdA Venture Fund Investors Mayfield Fund Crest Communications Partners LP CEA Capital Partners USA LP ABN AMRO Capital USA Inc Access Technologies partners Qwest Communications Microsoft Principal Officers Gerald K Dinsmore President and CEO Terri Compton Executive Vice President and COO William D Myers Senior Vice President Finance and Strategic Planning CFO Rex A Humston Senior Vice President Engineering and Chief Technology Officer Quantum Shift wwwquantumshiftcom formerly MVXcom On May MVXCOM changed its name to QuantumShift to better reflect the wideranging changes it is bringing to the telecommunications industry The company offers businesses onestopshopping for telecommunications solutions and implementation strategies Through alliances with US based and international companies it provides an array of communications services from local and long distance to frame relay and ISDN Venture Fund Investors Mayfield Fund Texas Pacific Group Francisco Partners Principal Officers Scott Schaefer President and CEO Edward A Brinskele CoFounder and Chief Technology Officer ThinkLink wwwthinklinkcom ThinkLink is a telecommunications applications service provider offering unified messaging Users are assigned a local number and an number All calls faxes and emails made to the users home office or other locations can be accessed by the user over the phone The service can be bundled and branded by ISPs Internet portals and other companies who want to provide customers with the latest communication technology Venture Fund Investors Mayfield Fund Softbank Technology Ventures Principal Officers David B Ward President and CEO ADVERTISEMENT Subscribe to IPO Express and you can receive company reports Daily wrapups and Weekly summaries of the IPO market sent direct to your desktop Go to for more information COMPANIES MENTIONED IN THIS ISSUE ABN AMRO Capital USA Inc Access Technologies partners Alta Partners American Biogenetic Sciences Inc ATT Bayer AG BioScience CEA Capital Partners USA LP Chase Communications Ventures Crest Communications Partners LP Dell Flashcom Francisco Partners GIMV Investors HealthCare Ventures Helicon Therapeutics Intel Corporation Intira Corporation Jato Communications Johnson Johnson Life Science Ventures Mayfield Fund Memory Pharmaceuticals Corp Microsoft MVXCOM NEA NeoTherapeutics Inc Oxford Bioscience Partners Pfizer Inc Quantum Shift QuantumShift Qwest Communications Shire Pharmaceuticals Group plc Softbank Technology Ventures Spectrum Equity SR One Texas Pacific Group The Mayfield Fund ThinkLink VenRock Associates PEOPLE MENTIONED IN THIS ISSUE Edward A Brinskele David S Boone M Wayne Boylston Robert S Cohen Terri Compton Gerald K Dinsmore Walter Gilbert Rex A Humston Eric Kandel Joanne M Leonard William D Myers Richard Rasmus Scott Schaefer Bernie Schneider John Steensen Axel Unterbeck David B Ward UNSUBSCRIBE INSTRUCTIONS To unsubscribe from the SECrets Newsletter go to authupdateinfoasp and deselect the free newsletter option If you need your user name or password go to usernameasp For help contact Copyright EDGAR Online DISCLAIMER The EDGAR Online report contains observations of its editor Tim Middleton a consultant of EDGAR Online and is for informational purposes only These statements and expressions are the sole opinions of Mr Middleton and EDGAR Online does not endorse nor necessarily agree on such statements and expressions Factual statements in this report are made as of the date stated and are subject to change without notice Nothing contained herein shall be deemed to be recommendations to buy hold or sell securities nor shall it purport to be a complete analysis of the companies mentioned While the information contained in this Report and the opinions contained herein are based on sources believed to be reliable neither Mr Middleton nor EDGAR Online have independently verified the facts assumptions andor estimates that may be contained in this Report Accordingly no representation or warranty expressed or implied is made as to and no reliance should be placed on the fairness accuracy completeness or correctness of the information and opinions contained in this Report 
